GARY W. PACE, PH.D.

Corporate Board Profile

Tech Score: 20/100

← Back to All Directors

Software Technology Evidence

1 mention(s) identify GARY W. PACE, PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
Cardiff Oncology, Inc. 2022-04-14 Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology where he was a Fulbright Fellow and General Foods Scholar. The Board believes that Dr. Pace’s years of experience providing strategic advisory services to complex organizations... provides him with the qualifications and skills to serve as a director. Dr. Pace holds a Ph.D. from MIT and has extensive experience in biopharmaceuticals and technology, indicating strong technical and scientific skills that likely include programming or related expertise.

Cardiff Oncology, Inc.

Filing Date Source Excerpt
2020-03-04 Dr. Pace is a seasoned biopharmaceutical executive with over 40 years of experience in the industry. He as co-founded several early stage life science companies, where he built products from the laboratory to commercialization.
2021-04-28 Dr. Pace is a seasoned biopharmaceutical executive with over 40 years of experience... The Board believes that Dr. Pace’s years of experience providing strategic advisory services... provides him with the qualifications and skills to serve as a director.
2022-04-14 Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology where he was a Fulbright Fellow and General Foods Scholar. The Board believes that Dr. Pace’s years of experience providing strategic advisory services to complex organizations... provides him with the qualifications and skills to serve as a director.
2023-04-27 Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology where he was a Fulbright Fellow and General Foods Scholar.
2024-04-25 Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology where he was a Fulbright Fellow and General Foods Scholar. The Board believes that Dr. Pace’s years of experience providing strategic advisory services to complex organizations, including as a public company director provides him with the qualifications and skills to serve as a director.

Data sourced from SEC filings. Last updated: 2026-02-03